TRVI (Trevi Pharma) Yalpi marja

Trevi Corp (TRVI) korporativ emblemasi va logotipi

Trevi Therapeutics (TRVI) kompaniyasining istiqbollari yo'tal va qichishishni davolash uchun mo'ljallangan Nalbuphine ER ning patent himoyasiga bog'liq. Valo martaba tendentsiyasi ushbu dinamikani tasdiqlaydi, bunda ko'rsatkich 0.00 atrofida saqlanmoqda. AQShda joylashgan tadqiqot markazi yetarli darajada xizmat ko'rsatilmagan terapevtik nishalarga e'tibor qaratadi. Kompaniyaga tegishli ekologik profil laboratoriya standartlariga rioya qilish va raqamli hujjatlashtirishga o'tish bilan cheklangan.

Trevi Pharma - TRVI Yalpi marja (davr: 04.07.2022 - 20.11.2026)

Trevi Pharma (TRVI) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Fundamental baholash:TRVI - Trevi Therapeutics, Inc.
Trevi Therapeutics Inc ishlab chiqargan mahsulot

Neuro-respirator bozorini egallash uchun Haduvio dori vositasining ishlab chiqilishi klinik sinovlar bosqichida Trevi Therapeutics (TRVI) kompaniyasining xarajatlar tuzilmasini belgilaydi. Yalpi foyda marjasidagi o'zgarishlarni tahlil qilish orqali investor tushumning bevosita ishlab chiqarish xarajatlari chegirilgan qismini baholaydi, bu esa texnologiyani monetizatsiya qilish samaradorligini va biznesni kengaytirish jarayonida kompaniyaning operatsion xatarlarga nisbatan kapital barqarorligi darajasini aniqlash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi foyda bo'yicha rentabellik PRAX (Praxis Medicines)|Anavex Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik CeriBell CBLL|Yalpi foyda bo'yicha sotuv rentabelligi Prothena Biosciences (PRTA)|ALEC: Yalpi foyda bo'yicha rentabellik|ANNX - Yalpi marja|Omeros Corp. (OMER) - Yalpi rentabellik|Yalpi foyda marjasi Neurogene Inc. (NGNE)|Yalpi foyda bo'yicha rentabellik ACIU|Yalpi rentabellik VYGR|Yalpi rentabellik Neumora (NMRA)|SCLX - Yalpi foyda marjasi|Yalpi marja TVGN (Tevogen Bio Holdings Inc.)|Yalpi foyda normasi ACOG|Cognition Therapeutics Inc. - Yalpi marja|IKT - Yalpi marja|SAVA: Yalpi marja|Assertio Holdings, Inc. - Yalpi foyda normasi|COYA (Coya) - Yalpi marja|Sotuvning yalpi rentabelligi VTGN (Vistagen Therapeutics)|Yalpi rentabellik Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik CervoMed, Inc. CRVO|Yalpi marja Alterity Therapeutics ATHE|CLNN: Yalpi foyda bo'yicha rentabellik|PEPG (pepgen.com) - Sotuvning yalpi rentabelligi|Jupiter Neurosciences Inc (JUNS) - Yalpi rentabellik|Relmada Therapeutics - Yalpi foyda normasi|ANVS (Annovis Bio Inc) - Yalpi marja|GRCE: Yalpi foyda normasi|Yalpi rentabellik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Yalpi foyda normasi|Yalpi rentabellik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Yalpi foyda marjasi|MTVA: Yalpi foyda bo'yicha rentabellik|NeurAxis, Inc (NRXS) - Yalpi foyda bo'yicha rentabellik|HSDT: Yalpi marja|PASG - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Neuphoria Therapeutics, Inc.|Yalpi rentabellik NERV|Yalpi marja ATHA|ADXN (Addex Therapeutics Ltd) - Yalpi foyda normasi|Yalpi rentabellik alzamend.com ALZN|Yalpi foyda bo'yicha sotuv rentabelligi Cyclerion Therapeutics (CYCN)|Protagenic - Yalpi marja|Yalpi foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Yalpi marja|Avenue Therapeutics Inc. (ATXI) - Yalpi marja|BCLI (BrainStorm Cell Therapeutics Inc.) - Yalpi marja|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)